UBS Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-51,213
Closed -$6.66K 9102
2023
Q1
$6.66K Sell
51,213
-32,510
-39% -$4.23K ﹤0.01% 6805
2022
Q4
$13.4K Buy
83,723
+27,752
+50% +$4.44K ﹤0.01% 6982
2022
Q3
$36K Buy
55,971
+4,839
+9% +$3.11K ﹤0.01% 5597
2022
Q2
$124K Hold
51,132
﹤0.01% 4276
2022
Q1
$207K Sell
51,132
-7,291
-12% -$29.5K ﹤0.01% 4345
2021
Q4
$468K Buy
58,423
+18,425
+46% +$148K ﹤0.01% 4032
2021
Q3
$772K Buy
39,998
+22,986
+135% +$444K ﹤0.01% 3435
2021
Q2
$235K Buy
17,012
+3,161
+23% +$43.7K ﹤0.01% 4226
2021
Q1
$125K Buy
13,851
+11,531
+497% +$104K ﹤0.01% 4811
2020
Q4
$13K Sell
2,320
-1,473
-39% -$8.25K ﹤0.01% 6285
2020
Q3
$12K Buy
3,793
+2,740
+260% +$8.67K ﹤0.01% 5848
2020
Q2
$3K Sell
1,053
-781
-43% -$2.23K ﹤0.01% 6715
2020
Q1
$4K Buy
1,834
+781
+74% +$1.7K ﹤0.01% 6508
2019
Q4
$5K Hold
1,053
﹤0.01% 6533
2019
Q3
$5K Sell
1,053
-2,491
-70% -$11.8K ﹤0.01% 6536
2019
Q2
$26K Buy
3,544
+627
+21% +$4.6K ﹤0.01% 5578
2019
Q1
$16K Sell
2,917
-9,595
-77% -$52.6K ﹤0.01% 5680
2018
Q4
$19K Sell
12,512
-769
-6% -$1.17K ﹤0.01% 5925
2018
Q3
$54K Buy
13,281
+1,441
+12% +$5.86K ﹤0.01% 5221
2018
Q2
$46K Sell
11,840
-2,157
-15% -$8.38K ﹤0.01% 5143
2018
Q1
$47K Buy
13,997
+1,086
+8% +$3.65K ﹤0.01% 4912
2017
Q4
$89K Buy
12,911
+1,071
+9% +$7.38K ﹤0.01% 4510
2017
Q3
$76K Buy
11,840
+11,787
+22,240% +$75.7K ﹤0.01% 4633
2017
Q2
$0 Sell
53
-1
-2% ﹤0.01% 6935
2017
Q1
$1K Sell
54
-9
-14% -$167 ﹤0.01% 6556
2016
Q4
$1K Sell
63
-14
-18% -$222 ﹤0.01% 6663
2016
Q3
$9K Buy
77
+14
+22% +$1.64K ﹤0.01% 5943
2016
Q2
$5K Hold
63
﹤0.01% 6244
2016
Q1
$5K Sell
63
-214
-77% -$17K ﹤0.01% 6160
2015
Q4
$25K Buy
277
+14
+5% +$1.26K ﹤0.01% 5372
2015
Q3
$29K Buy
263
+91
+53% +$10K ﹤0.01% 5144
2015
Q2
$17K Sell
172
-21
-11% -$2.08K ﹤0.01% 5631
2015
Q1
$21K Buy
193
+130
+206% +$14.1K ﹤0.01% 5359
2014
Q4
$6K Buy
+63
New +$6K ﹤0.01% 6278